We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for atezolizumab (Roche Products Pty Limited)
Active ingredients
atezolizumab
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Tablet
Indication
Treatment of small cell lung cancer
Therapeutic area
Oncology